Medyria AG
Advanced and intuitive methods for the visualization and con
Medyria has developed a unique technology for the direct measurement of the Blood Flow Velocity (BFV) and is developing medical devices that integrates the BFV sensor.
Recently we started the development of the PyCath, the only microcatheter on the planet earth that allows the full assessment of the heart physiology with a direct blood flow velocity measurement. This has a huge benefit for all patients, because completes the common coronary coronary study with an assessment of the microcirculation, bringing the eligibility of angina pectoris patients from 50% to 100%.
Besides this main project Medyria offers its sensing technology though an OEM business model that is successfully leading to the development of new cardiovascular devices functioning on the BFV measurement.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
17.07.2025
Medyria secures CHF 1.5M to advance PyCath development and expand globally (venturelab.swiss)
16.07.2025
Medyria secures CHF 1.5 million to accelerate development of its medical device (startupticker.ch)
09.05.2025
Milestones achievements for life sciences startups (startupticker.ch)
27.11.2023
Sparks IPO Academy prepares new cohort for next move (startupticker.ch)
11.01.2023
Medyria secures CHF 3.7 million to bring novel diagnostic device closer to market entry (venturelab.swiss)
01.04.2024
Pre-Clinical Phase concluded
01.04.2024
Pre-Clinical phase concluded
02.01.2023
Close 3.7 M Equity round
15.08.2022
OEM Development agreement signed
No Jobs
Videos
SCSN 2019
Trackcath Video
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
IMD Startup Competition
The IMD Startup Competition provides an unique opportunity for regional technology startups to benefit from the help and insights of a team of dedicated, experienced IMD participants from the MBA and the Executive MBA programs.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Medyria AG
Advanced and intuitive methods for the visualization and con
Website:
www.medyria.com
Headquarter:
Winterthur
Foundation Date:
January 2012
Technology:
- Medtech
Sectors:
- Cardiovascular
Support received
